Key result
Comprehensive CV risk assessment alongside lifestyle and medical interventions drives effective primary prevention.
Why the study?
Cardiovascular disease is a leading global health concern, making effective primary prevention strategies essential to mitigate its impact.
This review provides a comprehensive overview of current risk assessment strategies, emerging biomarkers, and lifestyle modifications essential for the primary prevention of cardiovascular disease.
Answers are grounded in this paper and cite their sources.
May guide primary prevention strategies; leaves open prospective validation of emerging biomarkers.
Cardiovascular disease (CVD) is a leading global health concern, and effective primary prevention strategies are essential to mitigate its impact. This comprehensive review examines current risk assessment strategies for primary prevention of CVD, emphasizing the importance of early identification and intervention to reduce disease incidence. Traditional risk factors such as hypertension, hyperlipidemia, smoking, and lifestyle choices are discussed alongside emerging factors, including genetic predispositions and biomarkers. The review evaluates various risk assessment tools and models, such as the Framingham risk score, atherosclerotic CVD risk calculator, QRISK, and Reynolds risk score, highlighting their methodologies, strengths, and limitations. Additionally, the review explores lifestyle modifications, including dietary changes, physical activity, weight management, smoking cessation, and pharmacological interventions like statins and antihypertensives. Special considerations for different populations, including the elderly, women, and those with a family history of CVD, are addressed. Future directions in cardiovascular risk assessment are also discussed, focusing on technological advancements and personalized medicine. This review aims to enhance the implementation of effective primary prevention measures and improve cardiovascular health outcomes by providing a thorough analysis of risk assessment strategies.
No takes yet. Share an insight, caveat, or question.
Karwa et al. (2024) conducted a review in Cardiovascular disease (primary prevention). Cardiovascular risk assessment and primary prevention strategies was evaluated. Comprehensive cardiovascular risk assessment, utilizing tools like the Framingham and ASCVD calculators alongside lifestyle and pharmacological interventions, is crucial for effective primary prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: